Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020

    Peter A. Everts, Kentaro Onishi, Prathap Jayaram, José Fábio Lana, Kenneth Mautner
    TLDR PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.
    In 2020, the understanding of Platelet-Rich Plasma (PRP) in regenerative medicine was evolving, with challenges in standardizing preparation methods and classifications. PRP showed promise in treating musculoskeletal disorders and enhancing tissue repair due to its regenerative capabilities, attributed to platelet-derived growth factors and cytokines. However, inconsistencies in clinical outcomes were noted, largely due to variability in PRP preparation and lack of standardization. The document highlighted the roles of leukocytes in immune modulation and the impact of platelet-derived serotonin on inflammation and pain. Despite these challenges, PRP remained a popular treatment option, with ongoing research aimed at optimizing its therapeutic applications and understanding its molecular mechanisms.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 108 results

    Similar Research

    5 / 1000+ results